¼±Ãµ³¶¼º»ù¸ð¾ç±âÇü¿¡¼ Thyroid Transcription Factor-1 °ú bcl-2ÀÇ ¸é¿ª¹ßÇö
Immunoexpressions of Thyroid Transcription Factor-1 and bcl-2 in Congenital Cystic Adenomatoid Malformation
±è³ª·¡, ±èµ¿ÈÆ, ±è±³¿µ, ±è´ë½Ä, ÇÑÁ¤È£,
¼Ò¼Ó »ó¼¼Á¤º¸
±è³ª·¡ ( Kim Na-Rae )
Áö¹æ°ø»ç °³²º´¿ø º´¸®°ú
±èµ¿ÈÆ ( Kim Dong-Hoon )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø º´¸®Çб³½Ç
±è±³¿µ ( Kim Gou-Young )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø º´¸®Çб³½Ç
±è´ë½Ä ( Kim Dae-Shick )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø º´¸®Çб³½Ç
ÇÑÁ¤È£ ( Han Joung-Ho )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø º´¸®Çб³½Ç
KMID : 0357920030370010010
Abstract
Background: Congenital cystic adenomatoid malformation (CCAM) is a congenital abnormality of branching morphogenesis of the lung. Thyroid transcription factor-1 (TTF-1) is detected in human respiratory epithelial cells from 11 weeks of gestation, and at full term, TTF-1 expression is confined within type II epithelial cells and in some respiratory nonciliated bronchiolar epithelial cells. Immunoexpression of bcl-2 is intimately related to apoptosis during the development.
Methods: To elucidate the nature of the lesion, TTF-1 expression was evaluated in twenty-four cases of CCAM (eight cases of type 1 and sixteen cases of type 2) along with immunostaining for bcl-2. For the control group, four cases of fetal lungs (19 week-, 21 week-, 27 week- and 40 week-gestational age) were also evaluated. In all cases of CCAM, TTF-1 was detected in the nuclei of epithelial cells lining the cysts.
Results: TTF-1 was expressed in the majority of the bronchiolar-like epithelial cells of the cysts in CCAM types 1, and 2, where almost 100% of the lining cells of the cysts were TTF-1 positive with variable intensity, while negative TTF-1 expressions were found in the alveolar-like epithelium of the adjacent alveoli or distal nonciliated bronchi. For bcl-2 immunostaining, no lining epithelial cells of the cysts were stained except for the infiltrating lymphocytes. In the control group, strong immunoreactivities found in early fetal stages were absent in the full-term aged lung (40 gestational weeks).
Conclusion: These results support the hypothesis that CCAM types 1 and 2 reflect the abnormalities in lung morphogenesis and differentiation that are distinct from those for normally developed alveolar epithelium or adjacent bronchial epithelium, thus retaining the abnormal TTF-1 immunoreactions. Though restricted to CCAM types 1 and 2 in this study, CCAM might be related to TTF-1 rather than apoptosis in the morphogenesis of the developing lung.
Å°¿öµå
Cystic adenomatoid malformation of lung;Congenital;Thyroid transcription factor-1;bcl-2;Immunohistochemistry
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸